Virtus Fund Advisers’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $51.8K | Sell |
3,021
-7,457
| -71% | -$128K | 0.16% | 64 |
|
|
2024
Q3 | $209K | Sell |
10,478
-3,580
| -25% | -$71.6K | 0.85% | 9 |
|
|
2024
Q2 | $157K | Buy |
14,058
+713
| +5% | +$7.97K | 0.62% | 12 |
|
|
2024
Q1 | $88.1K | Buy |
13,345
+1,117
| +9% | +$7.37K | 0.31% | 35 |
|
|
2023
Q4 | $55.3K | Hold |
12,228
| – | – | 0.34% | 48 |
|
|
2023
Q3 | $43.8K | Buy |
12,228
+2,103
| +21% | +$7.53K | 0.31% | 56 |
|
|
2023
Q2 | $37.4K | Buy |
+10,125
| New | +$37.4K | 0.26% | 67 |
|